Evidence map›Paper›PMID 21673736›Full record

ArticleKidney international2011

Hypertension as a mitochondrial and metabolic disease.

Mingyu Liang

Abstract readComment
PubMed Publisher
In one paragraph

Article in Kidney international, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Review
  3. Human plasma metabolomics reveals metabolic targets for intervention in salt-sensitive hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Renal metabolism and hypertension.Nature communications · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Mingyu LiangDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Funding

VASOPRESSIN SECRETION AND CARDIOVASCULAR FUNCTIONP01HL029587 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI COWLEY, ALLEN W · 1985 to 2012
$24.1M
Research ServicesP01HL082798 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI COWLEY, ALLEN W · 2006 to 2015
$22.0M
Renal 11b-Hydroxysteroid Dehydrogenases and HypertensionR01HL077263 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LIANG, MINGYU · 2005 to 2008
$1.4M
MicroRNA-Target Pairs in the KidneyR21DK084405 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LIANG, MINGYU · 2009 to 2010
$418k
MicroRNA, the Kidney, and HypertensionR21HL085267 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LIANG, MINGYU · 2009 to 2010
$418k
NHLBI NIH HHS HL029587NHLBI NIH HHS HL077263NHLBI NIH HHS HL082798NHLBI NIH HHS HL085267NHLBI NIH HHS P01 HL082798NHLBI NIH HHS R01 HL077263NHLBI NIH HHS R21 HL085267NIDDK NIH HHS DK084405NIDDK NIH HHS R21 DK084405
6 · The paper itself

Abstract

The molecular pathophysiology of hypertension is probably like a jigsaw puzzle of different but overlapping sets of factors and pathways that vary from one patient or one group of patients to another. Mitochondrial and metabolic abnormalities could be crucial pieces of this puzzle.

Indexed as

AnimalsHumansHypertensionMaleMitochondriaNADPH OxidasesNADPH Oxidases

Identifiers

PMID21673736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.